Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases

Immunologic Research

Volumn 56, Issue 2-3, 2013, Pages 451-456

  Zafrir, Yaron ^a   Gilburd, Boris ^a   Carrasco, Marina Garcia ^a,b   Kivity, Shaye ^a,c   Sánchez Castañón, María ^d   López Hoyos, Marcos ^d   Mandel, Mathilda ^c   Szmyrka, Magdalena ^e   Shoenfeld, Yehuda ^a   Agmon Levin, Nancy ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c SHEBA MEDICAL CENTER   (Israel)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antinuclear antibodies (ANA); Autoimmune diseases; Chemiluminescent immunoassay kit; Indirect immunofluorescence assay (IIF)

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA ANTIBODY; PROTEIN M2;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOMATION; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME;

AGED; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNOASSAY; ITALY; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84879549985     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8416-9     Document Type: Article

References (41)

1. Holborow EJ, Weir DM, Johnson GD. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J. 1957;2:732-4.
2. Defendenti C, Atzeni F, Spina MF, et al. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Rev. 2011;10(3):150-4.
3. Agmon-Levin N, Shapira Y, Selmi C, et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun. 2010;34(1):55-8.
4. Von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995;24(5):323-58.
5. Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev. 2008;7(8):616-20.
6. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum. 2002;47:434-44. (Pubitemid 34856134)
7. Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613-9.
8. Burnham TK. Antinuclear antibodies in patients with malignancies. Lancet. 1972;26(2):436.
9. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997;40(9):1601-11. (Pubitemid 27426153)
10. Nilsson BO, Skogh T, Ernerudh J, et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun. 2006;27(4):281-8. (Pubitemid 46199125)
11. Lacroix-Desmazes S, Kaveri SV, Mouthon L, et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998;216(1-2):117-37. (Pubitemid 28440383)
12. Shoenfeld Yehuda, Cervera Ricard, Eric Gershwin M. Diagnostic criteria in autoimmune diseases. New York: Humana Press; 2008.
13. Jolly M, Smaron M, Olsen Utset T, Ellman M. Are isolated antinucleolar antibodies a marker of scleroderma? J Clin Rheumatol. 2003;9(5):291-5. (Pubitemid 37248930)
14. Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev. 2003;2(4):211-7. (Pubitemid 36793945)
15. Terjung B, Spengler U. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Clin Rev Allergy Immunol. 2005;28(2):115-33. (Pubitemid 41264858)
16. Fritzler MJ. The antinuclear antibody (ANA) test: last or lasting gasp? Arthritis Rheum. 2011;63(1):19-22.
17. Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific auto-antibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124:71-81. (Pubitemid 30053777)
18. Bickel YB, Barnett EV, Pearson CM. Immunofluorescent patterns and specificity of human antinuclear antibodies. Clin Exp Immunol. 1968;3(7):641-56.
19. Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett. 2006;27:861-74.
20. Wiik AS. Anti-nuclear antibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol. 2005;34(4):260-8. (Pubitemid 41215659)
21. Keren DF. Antinuclear antibody testing. Clin Lab Med. 2002;22:447-74. (Pubitemid 34755913)
22. Wanchu A. Antinuclear antibodies: clinical applications. J Postgrad Med. 2000;46(2):144-8.
23. Gniewek RA, Stites DP, McHugh TM, et al. Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol. 1997;4(2):185-8. (Pubitemid 27130231)
24. González C, Guevara P, Alarcón I, et al. Antinuclear antibodies (ANA) screening by enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: analytical and clinical evaluation. Clin Biochem. 2002;35(6):463-9. (Pubitemid 35284543)
25. Check W. New autoimmune tests seek acceptance. CAP Today. 1995;9:1-36.
26. Shovman O, Gilburd B, Barzilai O, et al. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann NY Acad Sci. 2005;1050:380-8. (Pubitemid 41129457)
27. Gilburd B, Abu-Shakra M, Shoenfeld Y, et al. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation - a homogeneous, multiplexed system. Clin Dev Immunol. 2004;11(1):53-6. (Pubitemid 38478564)
28. Nifli AP, Notas G, Mamoulaki M, et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods. 2006;311(1-2):189-97.
29. Hiemann R, Buttner T, Krieger T, et al. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev. 2009;9(1):17-22.
30. Melegari A, Bonaguri C, Russo A, et al. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev. 2012;11(10):713-6.
31. Rigon A, Buzzulini F, Soda P, et al. Novel opportunities in automated classification of antinuclear antibodies on HEp-2 cells. Autoimmun Rev. 2011;10(10):647-52.
32. Op De Beeck K, Vermeersch P, Verschueren P, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev. 2011;10(12):801-8.
33. Routsias JG, Tzioufas AG. Sjögren's syndrome-study of autoantigens and autoantibodies. Clin Rev Allergy Immunol. 2007;32(3):238-51. (Pubitemid 350242570)
34. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010;69(8):1420-2.
35. Ghillani P, Rouquette AM, Desgruelles C, et al. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases. Ann NY Acad Sci. 2007;1109:407-13. (Pubitemid 47511383)
36. Tan EM, Rodnan GP, Garcia I, et al. Diversity of antinuclear antibodies in patients with progressive sclerosis. Arthritis Rheum. 1980;32:617-25.
37. Basu D, Reveille JD. Anti-scl-70. Autoimmunity. 2005;38(1):65-72. (Pubitemid 40515005)
38. Riboldi P, Asero R, Origgi L, et al. Antinuclear antibodies in progressive systemic sclerosis. Clin Exp Rheumatol. 1985;3:205-11. (Pubitemid 15024955)
39. Mahler M, Silverman ED, Schulte-Pelkum J, Fritzler MJ. Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality? Autoimmun Rev. 2010;9(11):756-60.
40. Dahle C, Skogh T, Aberg AK, et al. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun. 2004;22(3):241-8. (Pubitemid 38369185)
41. Pollock W, Toh BH. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A. Clin Pathol. 1999;52:684-7. (Pubitemid 29456906)